This one hour symposium will focus on testing for respiratory viruses including SARS-CoV-2 and other seasonal respiratory viruses using molecular methods. The challenging and dynamic nature of this field will be highlighted along with a discussion as to how labs are addressing the evolution of testing needs.
During the flu season, several life-threatening seasonal viruses are co-circulating, such as IAV, IBV, HRSV, and SARS-CoV-2. Fast, simultaneous detection of these viruses is important for the management of certain population groups, such as hospitalized patients with symptoms of respiratory infection, children <2 years, the elderly, and immunocompromised patients. The WHO now recommends integrating SARS-CoV-2 into the influenza surveillance program. The FTD SARS-CoV-2/FluA/FluB/HRSV Assay* shows excellent clinical performance and is a new diagnostic tool suitable for the management of patients with symptoms of respiratory infection. Watch this scientific webinar, featuring two key opinion leaders, to learn more!
Pr. Georgia Gioula, PhD
Professor of Medical Microbiology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Greece (Chairwoman).
Dr. Nathalie Kin, PhD
Scientist, Siemens Healthineers, FTD R&D, Luxembourg